User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Current global guidelines for type 2 diabetes treatment

    ... may be associated with a moderate weight increase. Acarbose is an alpha glycosidase inhibitor that is less effective in reducing ...

  2. The pharmacology of type 2 diabetes: from oral to injective drugs

    ... Glucose-lowering drugs metformin Sulphonylureas Acarbose Glitazones Pioglitazone GLP-1 agonists DPP-IV inhibitors ...

  3. Recommended reading – key published papers from 2017

    ... insulins degludec, canagliflozin, once-weekly exenatide and acarbose. They provide context on these results by comparing them with earlier ...

  4. Frequently Asked Questions about Diabetes

    ... loss. Some studies also suggest that inhibitors of DPP-4 acarbose can induce modest weight reduction in such patients. In contrast, ...

  5. Management of Pre-diabetes in the Asia-Pacific region

    ... mg/dL (6.1 mmol/L) if no contraindications are present; or acarbose 50–100 mg three times daily. 12 Within the region, despite the ...

  6. Scientific Highlights: 2016 Latin American conference on cardiometabolic diseases management: health emergencies in focus

    ... and discontinued if there is < 5% body weight reduction. Acarbose, thiazolidenediones, angiotensin II inhibitors or bariatric surgery ...

  7. Scientific Highlights: 2015 Asia Pacific conference on cardiometabolic diseases management

    ... approved for obesity, e.g., orlistat, as well as metformin, acarbose and pioglitazone have proven effective in slowing progression to ...